VIVUS to Present at Upcoming Investor Conference

        Print
| Source: VIVUS, Inc.

MOUNTAIN VIEW, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment conference:

Wells Fargo Securities Research & Economics 2013 Healthcare Conference
June 18, 2013, 3:30pm EDT
Intercontinental Hotel - Boston, MA

A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ending December 31, 2012, as amended by the Form 10-K/A filed on April 30, 2013, and periodic reports filed with the Securities and Exchange Commission.

VIVUS, Inc.
Dana B. Shinbaum
Corporate Development & Investor Relations


Financial Media Relations:
Joele Frank, Wilkinson Brimmer Katcher
Jennifer Beugelmans

(212) 895-8692

Investor Relations:
The Trout Group
Brian Korb

646-378-2923